All In Biotech

Drug Trial Radar · NCT03539952

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

CHELATE STUDY: Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Last checked: Nov 19, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

77

Actual

Start

Sep 3, 2018

Primary completion

Aug 19, 2020

Study completion Jan 18, 2022

Sponsor

Lead sponsor
OrphalanIndustry
Sponsor type
Industry
First posted
May 30, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, open-label study with an active standard-of-care comparator (penicillamine)

Conditions

  • Wilson Disease

Interventions

  • Penicillamine (D1-W12)Drug

    Penicillamine during baseline period (D1-W12)

  • TETA 4HCL (W12-60)Drug

    TETA 4HCL during post randomisation and 1st extension period (W12-W60)

  • Penicillamine (W12-W60)Drug

    Penicillamine during rondomisation and 1st extension period period (W12-W60)

  • TETA 4HCL (60-<W108)Drug

    TETA 4HCL during 2nd extension period (W60-\<W108)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serum NCC ConcentrationTime frame: Week 36

Locations

15 sites in 9 countries. Site status is shown where the registry gives one.

  • Yale University School of Medicine

    New Haven, Connecticut

  • KU Leuven, Department of Clinical and Experimental Medicine

    Leuven, Belgium

  • Hospital Nossa Senhora das Graças (HNSG)

    Curitiba, Brazil

  • Nucleo de Pesquisa e Desenvolvimento de Medicamentos - Universidade Federal do Ceará - Rodolfo Teófilo

    Fortaleza, Brazil

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, Brazil

  • Hepato-gastroenterologisk afd

    Aarhus, Denmark

  • Hospital mother children

    Bron, France

  • Centre National de Référence Wilson, Hôpital Lariboisière

    Paris, France

  • Innere Medizin

    Heidelberg, Germany

  • Poliklinik Hepatologie/Transplantationsambulanz

    Munich, Germany

  • A.O. San Paolo Milano

    Milan, Italy

  • DiSCOG Gastroenterology Unit

    Padova, Italy

  • Institute of Psychiatry and Neurology

    Warsaw, Poland

  • Leeds Teaching Hospitals NHS Trust

    Leeds, United Kingdom

  • University of Surrey, Department of Clinical and Experimental Medicine

    Guildford, Surrey, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.